/assets/img/hottest3.png
/assets/img/hottest2.png

/assets/img/cw-stocks-3.png
/assets/img/red-line.jpg
/assets/img/cw-stocks.png
21ьз╕ Cweather-icon
/assets/img/hottest3.png
/assets/img/hottest2.png

/assets/img/cw-stocks-3.png
/assets/img/red-line.jpg
/assets/img/cw-stocks.png

Gemphire Therapeutics Inc. (GEMP) Is Up Sharply On Study Results

Markets2018-06-29
9 Views

Gemphire Therapeutics Inc. (GEMP) announced after the bell Thursday that its Phase 2b trial of gemcabene met its primary endpoint.

Source: RTTNews

Read More..
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.


BioNTech (Nasdaq: BNTX) and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China





/assets/img/wysh-jewels.png

/assets/img/hjli.png

/assets/img/Mars-Parachute-2.png

/assets/img/crweworld-podcast.jpg
Sponsored
Also read